119 related articles for article (PubMed ID: 18314632)
1. [Methylation status of LINE-1 sequences in patients with MDS or secondary AML].
Römermann D; Hasemeier B; Metzig K; Schlegelberger B; Länger F; Kreipe H; Lehmann U
Verh Dtsch Ges Pathol; 2007; 91():338-42. PubMed ID: 18314632
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic changes in therapy-related MDS/AML.
Voso MT; D'Alò F; Greco M; Fabiani E; Criscuolo M; Migliara G; Pagano L; Fianchi L; Guidi F; Hohaus S; Leone G
Chem Biol Interact; 2010 Mar; 184(1-2):46-9. PubMed ID: 19874806
[TBL] [Abstract][Full Text] [Related]
3. Semi-quantitative study of calcitonin gene methylation in myelodysplastic syndrome.
Wu S; Xie G; Bai R; Wang Y; Zhu P
Chin Med J (Engl); 1998 Aug; 111(8):690-3. PubMed ID: 11245020
[TBL] [Abstract][Full Text] [Related]
4. Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions.
Benetatos L; Dasoula A; Hatzimichael E; Syed N; Voukelatou M; Dranitsaris G; Bourantas KL; Crook T
Ann Hematol; 2011 Sep; 90(9):1037-45. PubMed ID: 21340720
[TBL] [Abstract][Full Text] [Related]
5. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
[TBL] [Abstract][Full Text] [Related]
6. Differential repetitive DNA methylation in multiple myeloma molecular subgroups.
Bollati V; Fabris S; Pegoraro V; Ronchetti D; Mosca L; Deliliers GL; Motta V; Bertazzi PA; Baccarelli A; Neri A
Carcinogenesis; 2009 Aug; 30(8):1330-5. PubMed ID: 19531770
[TBL] [Abstract][Full Text] [Related]
7. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes.
Benetatos L; Hatzimichael E; Dasoula A; Dranitsaris G; Tsiara S; Syrrou M; Georgiou I; Bourantas KL
Leuk Res; 2010 Feb; 34(2):148-53. PubMed ID: 19595458
[TBL] [Abstract][Full Text] [Related]
8. Gene-specific promoter hypermethylation without global hypomethylation in follicular thyroid cancer.
Lee JJ; Geli J; Larsson C; Wallin G; Karimi M; Zedenius J; Höög A; Foukakis T
Int J Oncol; 2008 Oct; 33(4):861-9. PubMed ID: 18813801
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modifications in AML and MDS.
Mahmud M; Stebbing J
Leuk Res; 2010 Feb; 34(2):139-40. PubMed ID: 19665226
[No Abstract] [Full Text] [Related]
10. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
Swolin B; Rödjer S; Westin J
Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338
[TBL] [Abstract][Full Text] [Related]
11. Using peripheral blood circulating DNAs to detect CpG global methylation status and genetic mutations in patients with myelodysplastic syndrome.
Iriyama C; Tomita A; Hoshino H; Adachi-Shirahata M; Furukawa-Hibi Y; Yamada K; Kiyoi H; Naoe T
Biochem Biophys Res Commun; 2012 Mar; 419(4):662-9. PubMed ID: 22382018
[TBL] [Abstract][Full Text] [Related]
12. LUMA (LUminometric Methylation Assay)--a high throughput method to the analysis of genomic DNA methylation.
Karimi M; Johansson S; Stach D; Corcoran M; Grandér D; Schalling M; Bakalkin G; Lyko F; Larsson C; Ekström TJ
Exp Cell Res; 2006 Jul; 312(11):1989-95. PubMed ID: 16624287
[TBL] [Abstract][Full Text] [Related]
13. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome.
Lin J; Yao DM; Qian J; Wang YL; Han LX; Jiang YW; Fei X; Cen JN; Chen ZX
Leuk Res; 2008 Oct; 32(10):1541-5. PubMed ID: 18367246
[TBL] [Abstract][Full Text] [Related]
14. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis.
Chalitchagorn K; Shuangshoti S; Hourpai N; Kongruttanachok N; Tangkijvanich P; Thong-ngam D; Voravud N; Sriuranpong V; Mutirangura A
Oncogene; 2004 Nov; 23(54):8841-6. PubMed ID: 15480421
[TBL] [Abstract][Full Text] [Related]
15. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes.
Zhou JD; Zhang TJ; Xu ZJ; Deng ZQ; Gu Y; Ma JC; Wen XM; Leng JY; Lin J; Chen SN; Qian J
Cell Death Dis; 2020 Nov; 11(11):997. PubMed ID: 33219204
[TBL] [Abstract][Full Text] [Related]
17. Global and regional CpG methylation in pheochromocytomas and abdominal paragangliomas: association to malignant behavior.
Geli J; Kiss N; Karimi M; Lee JJ; Bäckdahl M; Ekström TJ; Larsson C
Clin Cancer Res; 2008 May; 14(9):2551-9. PubMed ID: 18451216
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
Bernasconi P
Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941
[TBL] [Abstract][Full Text] [Related]
19. Quantitative comparison of CDKN2B methylation in pediatric and adult myelodysplastic syndromes.
Kim M; Kook H; Park HJ; Ahn HS; Lee KC; Lee KS; Park SK; Lim JY; Kim HK; Han DK; Lee DS;
Acta Haematol; 2013; 130(2):115-21. PubMed ID: 23571652
[TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic alterations of bone marrow stromal cells in myelodysplastic syndrome and acute myeloid leukemia patients.
Kim Y; Jekarl DW; Kim J; Kwon A; Choi H; Lee S; Kim YJ; Kim HJ; Kim Y; Oh IH; Kim M
Stem Cell Res; 2015 Mar; 14(2):177-84. PubMed ID: 25665922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]